Skip to content
HowShorted

Oruka Therapeutics, Inc. short interest in 2026

In 2026, Oruka Therapeutics, Inc.'s disclosed short interest ran from 10.83% of shares outstanding on 15 Jan 2026 to 11.51% on 15 Sep 2026, a change of +0.68 percentage points. The year's high was 15.19% on 30 Jun 2026 and its low 7.53% on 13 Mar 2026, averaging 11.10% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 15.60 days on 27 Feb 2026. Full history: Oruka Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Oruka Therapeutics, Inc. in 2026

2026 in figures

Start of year
10.83% (15 Jan 2026)
End of year
11.51% (15 Sep 2026)
Change
+0.68 pp
High
15.19% (30 Jun 2026)
Low
7.53% (13 Mar 2026)
Average
11.10%
Highest days to cover
15.60 (27 Feb 2026)
SEC filings marked
5

Every report in 2026

Oruka Therapeutics, Inc. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 202610.83%11.02
30 Jan 202610.14%8.88
13 Feb 20268.39%11.49
27 Feb 20269.23%15.60
13 Mar 20267.53%7.4810-K filed
31 Mar 20269.34%5.02
15 Apr 202611.44%4.04
30 Apr 202611.59%2.62results (8-K)
15 May 202610.37%3.5710-Q filed
29 May 202610.57%4.97
15 Jun 202611.44%6.08
30 Jun 202615.19%4.29
15 Jul 202614.65%6.24
31 Jul 202612.16%8.38
14 Aug 202612.54%11.3310-Q filed, results (8-K)
31 Aug 202611.77%9.27
15 Sep 202611.51%11.61

See also: Oruka Therapeutics, Inc.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.